Clinical trial
A First Time In Human Study To Assess The Compound GSK615915
NCT00400660 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00400660 |
|---|---|
| Title | A First Time In Human Study To Assess The Compound GSK615915 |
| Official title | First Time in Human, Single Dose and Repeat Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of GSK615915 |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Bronchospasm |
| Intervention type | Drug |
| Interventions | GSK615915A, Placebo |
| Enrollment | 46 |
| Start date | Nov 23, 2005 |
| Primary completion | Jul 3, 2006 |
| Completion | Jul 3, 2006 |
| First posted | Nov 17, 2006 |
| Last update posted | Sep 29, 2017 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: